Frisco, TX, United States of America

David Spencer

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Bellicum Pharmaceutics, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Spencer. Retrieved from https://idiyas.com/inventor/david-spencer-lqtjq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of David Spencer

Introduction

David Spencer, an accomplished inventor based in Frisco, TX, has made significant strides in the realm of immunology. With a focus on advancing T cell activation methods, he has developed a patented technology that holds promise for improving therapeutic approaches in cancer treatments. His commitment to innovation is exemplified by his sole patent, which delves into the intricate mechanisms of immune response modulation.

Latest Patents

Spencer's notable patent, titled "Costimulation of chimeric antigen receptors by MYD88 and CD40 polypeptides," encapsulates a novel approach to enhancing the activation of T cells and other immune cells. The technology is centered around methods designed to stimulate an immune response against specific target antigens. By employing chimeric MyD88- and CD40-derived polypeptides, the patent outlines methods for generating therapeutic cells that express chimeric antigen receptors, thus opening pathways for more effective patient treatments through enhanced immunological responses.

Career Highlights

Spencer's career has been interwoven with his role at Bellicum Pharmaceuticals, Inc., a pioneering company dedicated to developing advanced cellular immunotherapies. His expertise and innovative spirit have contributed to the company's mission to advance the field of immunotherapy, showcasing his ability to integrate scientific research with practical applications. His legislative patent illustrates not only his intellect but also his dedication to improving healthcare outcomes for patients.

Collaborations

Throughout his journey, David Spencer has collaborated with notable colleagues, including Aaron Edward Foster and Kevin Slawin. These partnerships have fostered a collaborative environment that promotes the cross-pollination of ideas, ultimately contributing to the success and advancement of the groundbreaking technologies developed at Bellicum Pharmaceuticals.

Conclusion

In conclusion, David Spencer is a testament to the power of innovation within the scientific realm. His groundbreaking patent in immunology speaks volumes of his dedication to exploring novel therapeutic avenues. As he continues to push the frontiers of medical research, the impacts of his inventions are bound to resonate within the healthcare field, offering hope to patients seeking effective treatment modalities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…